A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

PHASE2CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

March 26, 2017

Primary Completion Date

April 5, 2022

Study Completion Date

January 7, 2025

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Nivolumab

Specified dose on specified days

BIOLOGICAL

Ipilimumab

Specified dose on specified days

DRUG

Cabazitaxel

Specified dose on specified days

DRUG

Prednisone

Specified dose on specified days

Trial Locations (59)

1090

Local Institution - 0048, Vienna

2076

Local Institution - 0059, Wahroonga

2100

Local Institution - 0061, København Ø

2145

Local Institution - 0029, Westmead

2250

Local Institution - 0027, Gosford

3168

Local Institution - 0031, Clayton

4012

Local Institution - 0043, Woolloongabba

4215

Local Institution - 0028, Southport

5000

Local Institution - 0060, Odense

5112

Local Institution - 0030, Elizabeth Vale

8200

Local Institution - 0063, Aarhus N

9000

Local Institution - 0062, Aalborg

10029

Local Institution - 0001, New York

11042

Local Institution - 0065, Lake Success

12208

Local Institution - 0078, Albany

13273

Local Institution - 0004, Marseille

15706

Local Institution - 0023, Santiago Compostela

18105

Local Institution - 0047, Allentown

18107

Local Institution - 0036, Rostock

19104

Local Institution - 0010, Philadelphia

20133

Local Institution - 0052, Milan

28007

Local Institution - 0020, Madrid

28027

Local Institution - 0022, Madrid

28041

Local Institution - 0021, Madrid

29010

Local Institution - 0024, Málaga

29425

Local Institution - 0067, Charleston

30060

Local Institution - 0046, Marietta

37075

Local Institution - 0038, Göttingen

38114

Local Institution - 0041, Braunschweig

43100

Local Institution - 0072, Parma

44625

Local Institution - 0019, Herne

46483

Local Institution - 0035, Wesel

48149

Local Institution - 0018, Münster

52100

Local Institution - 0071, Arezzo

55404

Local Institution - 0076, Minneapolis

60637

Local Institution - 0011, Chicago

63000

Local Institution - 0009, Clermont-Ferrand

63110

Local Institution - 0008, St Louis

69008

Local Institution - 0005, Lyon

72076

Local Institution - 0033, Tübingen

72622

Local Institution - 0042, Nürtingen

77030

Local Institution - 0002, Houston

78731

Local Institution - 0079, Austin

80131

Local Institution - 0053, Napoli

81377

Local Institution - 0034, Munich

85711

Local Institution - 0074, Tucson

89169

Local Institution - 0075, Las Vegas

90419

Local Institution - 0037, Nuremberg

94805

Local Institution - 0003, Villejuif

97223

Local Institution - 0077, Tigard

H2X 0A9

Local Institution - 0044, Montreal

01307

Local Institution - 0032, Dresden

07747

Local Institution - 0017, Jena

05100

Local Institution - 0051, Terni

30-688

Local Institution - 0055, Krakow

75-581

Local Institution - 0066, Koszalin

02-781

Local Institution - 0054, Warsaw

06006

Local Institution - 0026, Badajoz

08003

Local Institution - 0025, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY